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β-lactams, such as penicillin, are the most
widely prescribed class of antibiotics.
In response to their extensive use and
misuse, bacteria have become resistant to
a growing number of these drugs. Many
antibiotic-resistant bacteria express the
enzyme β-lactamase, the most widespread
resistance mechanism to β-lactams.
These enzymes cleave the defining lactam
ring, rendering the antibiotic inactive
against its original cellular target, thereby
allowing the bacteria to survive. As a
result, antibiotic resistance has become
a critical concern to human health. An
example of an antibiotic resistant bacterial
species that has shown pathogenic
properties is Acinetobacter baumannii.
A significant portion of the resistance of
this organism is due to its expression of
the β-lactamase, Acinetobacter-derived
cephalosporinase-7 (ADC-7). In order
to combat the antibiotic resistance in
Acinetobacter, molecules were designed
that could potentially bind ADC-7 and
inhibit its ability to break down antibiotics.
However, to facilitate the characterization
and optimization of inhibitor design, the
molecular structure of ADC-7 needs to
be determined. In collaboration with
Dr. Rachel Powers, we have recently
determined the structure of ADC-7 with
and without a bound inhibitory molecule.
Currently, we are attempting to identify
a specific molecule that can bind ADC-7
with high affinity and sufficiently inhibit
ADC-7 to be considered an effective drug.

μM, and competition kinetics performed
with CR192 resulted in an average Ki
of 0.00045 μM. Even though S06017
binds ADC-7 with lower affinity than
related molecules, the question remains:
what specific parts of these molecules are
responsible for binding tightly to ADC-7?
By determining the X-ray crystal structure
of ADC-7 with S06017 bound in its active
site, it is possible to compare the specific
orientation and interactions involved
in inhibitor binding. In addition, by
comparing the ADC-7 structures in a
complex with different compounds, it
is possible to optimize the molecular
structure of compound that will serve
as the most efficient inhibitor of ADC7. Comparing all of the X-ray crystal
structures, as well as the KI values from
competition kinetics, will hopefully lead to
the discovery of an inhibitory drug that will
significantly inhibit ADC-7, which could
aid in combatting antibiotic resistance in
Acinetobacter baumannii.
*This scholar and faculty mentor have
requested that only an abstract be
published.

The goal of this study is to characterize
a promising new inhibitory compound
of ADC-7 (S06017) and determine
the efficacy with which this drug can
inactivate the β-lactamase enzyme. In
order to determine whether the inhibitor
substantially decreases the enzyme activity,
competition kinetics were performed with
S06017 against a diagnostic substrate
of ADC-7 (nitrocefin). Competition
kinetics assays yield a Ki value, which is
a measurement of the ADC-7/inhibitor
binding affinity, with lower Ki values
indicating higher binding affinities. While
the resulting Ki of 6.108 μM demonstrates
that S06017 does bind and inhibit
ADC-7’s ability to break down nitrocefin,
the ADC-7/S06017 binding affinity is
weaker than other related compounds.
For example, the inhibitory compound
S02030 binds ADC-7 with a Ki of 0.0373
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